Pravastatina [Spanish] en es it fr

Pravastatina [Spanish] Brand names, Pravastatina [Spanish] Analogs

Pravastatina [Spanish] Brand Names Mixture

  • No information avaliable

Pravastatina [Spanish] Chemical_Formula


Pravastatina [Spanish] RX_link

Pravastatina [Spanish] fda sheet

Pravastatina_[Spanish] FDA

Pravastatina [Spanish] msds (material safety sheet)

Pravastatina [Spanish] Synthesis Reference

A. Terahara, M.Tanaka, U.S. Pat. 4,346,227(1982)

Pravastatina [Spanish] Molecular Weight

424.528 g/mol

Pravastatina [Spanish] Melting Point


Pravastatina [Spanish] H2O Solubility


Pravastatina [Spanish] State


Pravastatina [Spanish] LogP


Pravastatina [Spanish] Dosage Forms


Pravastatina [Spanish] Indication

For the treatment of hypercholesterolemia to reduce the risk of myocardial infarction.

Pravastatina [Spanish] Pharmacology

Pravastatin, an antilipemic agent, is used to treat primary hypercholesterolemia. Unlike lovastatin and simvastatin, pravastatin is relatively hydrophilic and does not require hydrolysis for activation.

Pravastatina [Spanish] Absorption

Average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.

Pravastatina [Spanish] side effects and Toxicity

Rhabdomyolysis; LD50=mg/kg (orally in rat)

Pravastatina [Spanish] Patient Information

Patients should be advised to report promptly unexplained muscle pain, tenderness or weakness, particularly if accompanied by malaise or fever.

Pravastatina [Spanish] Organisms Affected

Humans and other mammals